Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you take amitriptyline and are considering Mounjaro for weight management, the short answer is: there is no outright prohibition, but the combination requires careful clinical review. Amitriptyline is a tricyclic antidepressant that also affects gastric motility — and Mounjaro already slows gastric emptying as part of how it works — so a prescriber needs to weigh both medicines together before any decision is made. Mounjaro (tirzepatide) is a prescription-only medicine; suitability is always assessed by a clinician, not determined by a checklist.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro activates both GIP and GLP-1 receptors, and one of its established effects is slowing how quickly food leaves the stomach. For most people this is a feature: it prolongs fullness and reduces appetite. Amitriptyline, meanwhile, has strong anticholinergic properties, it quietens some of the nerve signals that keep the gut moving at its normal pace. When both medicines are present, there is a plausible physiological reason to expect their gut-slowing effects to overlap.
In practice this matters in two ways. First, tolerability: nausea, constipation and bloating are already among the most commonly reported side effects of Mounjaro, and anyone whose gut is already running a little slower because of amitriptyline may find those symptoms more pronounced, particularly in the first few weeks of treatment or after a dose increase. Second, absorption: when gastric emptying slows substantially, the timing of how oral medicines reach the small intestine can shift. For a medicine like amitriptyline, which is generally taken at a stable daily dose, this is unlikely to cause a dramatic clinical problem, but it is something a prescriber managing your amitriptyline should be aware of. The NHS tirzepatide medicines page notes that Mounjaro can affect how other oral medicines are absorbed, and advises patients to tell their doctor about all medicines they take.
Neither of these points means the combination is unsafe or ruled out. They mean it deserves a proper clinical conversation, not a quick scroll through a forum.
When you complete a consultation for Mounjaro, the prescriber is not simply running your BMI against a cut-off. They are reading a full medicines history. If you take amitriptyline, the questions that matter include: what dose, what for, and how long, because amitriptyline is prescribed at very different doses for pain, sleep, anxiety and depression, and the relevant considerations differ. A low dose taken for nerve pain carries different clinical weight than a higher dose prescribed for depression alongside other medicines.
If you are already experiencing constipation or other GI symptoms on amitriptyline, that is important context. If you are also taking other medicines that affect gut motility or absorption, that adds another layer. The BNF entry for tirzepatide lists interactions and cautions that a prescriber will cross-reference against your profile. Your own GP, who holds your full history, is well placed to input into this decision, and at nume, GP notification is part of the standard process in line with GPhC guidance.
It is worth knowing that the question of which medicines are compatible with Mounjaro is genuinely one of the things our prescribers look at for every patient. You're not unusual for asking it, and you're right to ask it before starting, not after.
If you are on amitriptyline and want to explore whether Mounjaro is an option, the most useful thing you can do is list every medicine you take (dose included) and flag your current GI tolerability honestly when you complete a consultation, and if you are wondering whether you can get Mounjaro online, our prescribers review your full medicines list as part of that process. If you are curious about how other medicines sit alongside Mounjaro, the pattern is similar: questions about taking Mounjaro with sertraline or combining Mounjaro with chronic kidney disease follow the same logic of individual clinical review rather than blanket rules.
Eligibility for Mounjaro in the UK starts with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol, though BMI alone never tells the whole story. The BMI requirements for Mounjaro page has more detail on how that threshold works in practice. If you want to understand what the consultation involves before committing to anything, our Mounjaro overview covers the full process.
For anyone wondering about cost (because it is a reasonable question alongside all the clinical ones) a plain summary of how Mounjaro is privately priced is on the Mounjaro cost page. The price includes the consultation, prescription and delivery; there are no separate fees to add on.
If you are ready to have your medicines reviewed by a clinician, you can check your eligibility with a free consultation today. A GPhC-registered prescriber will read your answers (your full medicines list included) and let you know whether Mounjaro is clinically appropriate for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.